NHE-1 participates in isoproterenol-induced downregulation of SERCA2a and development of cardiac remodeling in rat hearts

Am J Physiol Heart Circ Physiol. 2011 Nov;301(5):H2154-60. doi: 10.1152/ajpheart.00483.2011. Epub 2011 Aug 19.

Abstract

Impaired Ca(2+) handling is one of the main characteristics in heart failure patients. Recently, we reported abnormal expressions of Ca(2+)-handling proteins in isoproterenol (ISO)-induced hypertrophied rat hearts. On the other hand, Na(+)/H(+) exchanger (NHE)-1 inhibitor has been demonstrated to exert beneficial effects in ischemic-reperfusion injury and in the development of cardiac remodeling. The aims of the present study are to investigate the role of NHE-1 on Ca(2+) handling and development of cardiac hypertrophy in ISO-infused rats. Male Wistar rats were randomly divided into vehicle [control (CTL)] and ISO groups without or with pretreatment with a selective NHE-1 inhibitor, BIIB-723. ISO infusion for 1 wk significantly increased the ratios of heart to body weight and left ventricle (LV) to body weight and collagen accumulation. All of these increases were antagonized by coadministration with BIIB-723. The ISO-induced significant increase in LV wall thickness was suppressed significantly (P < 0.05) by BIIB-723. ISO-induced decreases in cardiac stroke volume and a total mechanical energy per beat index, systolic pressure-volume area at midrange LV volume, were normalized by BIIB-723. The markedly higher expression of NHE-1 protein in the ISO group than that in CTL group was suppressed (P < 0.05) by BIIB-723. Surprisingly, ISO induced downregulation of the important Ca(2+)-handling protein sarcoplasmic reticulum Ca(2+)-ATPase 2a, the expression of which was also normalized by BIIB-723 without changes in phosphorylated phospholamban (PLB)/PLB expression. We conclude that NHE-1 contributes to ISO-induced abnormal Ca(2+) handling associated with cardiac hypertrophy. Inhibition of NHE-1 ameliorates cardiac Ca(2+)-handling impairment and prevents the development of cardiac dysfunction in ISO-infused rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium Signaling* / drug effects
  • Calcium-Binding Proteins / metabolism
  • Cardiomegaly / chemically induced
  • Cardiomegaly / enzymology*
  • Cardiomegaly / pathology
  • Cardiomegaly / physiopathology
  • Cardiomegaly / prevention & control
  • Collagen / metabolism
  • Disease Models, Animal
  • Down-Regulation
  • Guanidines / pharmacology
  • Heart Rate
  • Isoproterenol*
  • Male
  • Myocardium / enzymology*
  • Myocardium / pathology
  • Phosphorylation
  • Rats
  • Rats, Wistar
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases / metabolism*
  • Sodium-Hydrogen Exchanger 1
  • Sodium-Hydrogen Exchangers / antagonists & inhibitors
  • Sodium-Hydrogen Exchangers / metabolism*
  • Stroke Volume
  • Time Factors
  • Ventricular Function, Left
  • Ventricular Remodeling* / drug effects

Substances

  • Atp2a2 protein, rat
  • BIIB 723
  • Calcium-Binding Proteins
  • Guanidines
  • Slc9a1 protein, rat
  • Sodium-Hydrogen Exchanger 1
  • Sodium-Hydrogen Exchangers
  • phospholamban
  • Collagen
  • Sarcoplasmic Reticulum Calcium-Transporting ATPases
  • Isoproterenol